Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Coffey

Showing results (121-130 of 512) with videos related to

Pageof 52
Sort By:
Stroke|June 11, 2005
Is Bayesian analysis ready for use in phase III randomized clinical trials? Beware the sound of the sirensGeorge Howard, Christopher S Coffey, Gary R Cutter
Trends in Microbiology|July 4, 2012
Bacterial survival strategies suggest rethinking cancer cooperativityEshel Ben-Jacob, Donald S Coffey, Herbert Levine
Cancer Research|May 15, 1989
Cancer as a disease of DNA organization and dynamic cell structureK J Pienta, A W Partin, D S Coffey
Nature|July 10, 1986
Newly replicated DNA is associated with DNA topoisomerase II in cultured rat prostatic adenocarcinoma cellsW G Nelson, L F Liu, D S Coffey
JONA'S Healthcare Law, Ethics and Regulation|May 29, 2000
Hospital executives and ethics committees: an effective collaborationB B Hilliard, B S Coffey, R B Johnson
Cancer Chemotherapy Reports|January 1, 1975
Specificity of cell membrane antigens in prostatic cancerG E Brannen, D M Gomolka, D S Coffey
Investigative Urology|September 1, 1975
The effects of 5-fluorouracil on prostatic DNA synthesisW R Sloan, D S Coffey, W W Scott
The Journal of Urology|July 1, 1977
Experimental models for the study of prostatic adenocarcinomaJ K Smolev, D S Coffey, W W Scott
Mechanisms of Ageing and Development|January 1, 1992
Characterization of nuclear morphology and nuclear matrices in ageing human fibroblastsK J Pienta, R H Getzenberg, D S Coffey
Progress in Clinical and Biological Research|January 1, 1979
New biochemical methods to determine androgen sensitivity of prostatic cancer: the relative enzymatic index (REI)J T Isaacs, W W Scott, D S Coffey
Pageof 52

Showing results (121-130 of 512) with videos related to

Sort By:
Pageof 52
Stroke|June 11, 2005
Is Bayesian analysis ready for use in phase III randomized clinical trials? Beware the sound of the sirensGeorge Howard, Christopher S Coffey, Gary R Cutter
Trends in Microbiology|July 4, 2012
Bacterial survival strategies suggest rethinking cancer cooperativityEshel Ben-Jacob, Donald S Coffey, Herbert Levine
Cancer Research|May 15, 1989
Cancer as a disease of DNA organization and dynamic cell structureK J Pienta, A W Partin, D S Coffey
Nature|July 10, 1986
Newly replicated DNA is associated with DNA topoisomerase II in cultured rat prostatic adenocarcinoma cellsW G Nelson, L F Liu, D S Coffey
JONA'S Healthcare Law, Ethics and Regulation|May 29, 2000
Hospital executives and ethics committees: an effective collaborationB B Hilliard, B S Coffey, R B Johnson
Cancer Chemotherapy Reports|January 1, 1975
Specificity of cell membrane antigens in prostatic cancerG E Brannen, D M Gomolka, D S Coffey
Investigative Urology|September 1, 1975
The effects of 5-fluorouracil on prostatic DNA synthesisW R Sloan, D S Coffey, W W Scott
The Journal of Urology|July 1, 1977
Experimental models for the study of prostatic adenocarcinomaJ K Smolev, D S Coffey, W W Scott
Mechanisms of Ageing and Development|January 1, 1992
Characterization of nuclear morphology and nuclear matrices in ageing human fibroblastsK J Pienta, R H Getzenberg, D S Coffey
Progress in Clinical and Biological Research|January 1, 1979
New biochemical methods to determine androgen sensitivity of prostatic cancer: the relative enzymatic index (REI)J T Isaacs, W W Scott, D S Coffey
Pageof 52